Literature DB >> 14681897

Minocycline is protective in a mouse model of Huntington's disease.

Steven Hersch, Klaus Fink, Jean Paul Vonsattel, Robert M Friedlander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14681897     DOI： 10.1002/ana.21891

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  11 in total

1.  Lack of minocycline efficiency in genetic models of Huntington's disease.

Authors:  Stéphane Mievis; Marc Levivier; David Communi; Gilbert Vassart; Jacques Brotchi; Catherine Ledent; David Blum
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease.

Authors:  Xin Wang; Shan Zhu; Zhijuan Pei; Martin Drozda; Irina G Stavrovskaya; Steven J Del Signore; Kerry Cormier; Ethan M Shimony; Hongyan Wang; Robert J Ferrante; Bruce S Kristal; Robert M Friedlander
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

Review 3.  Drosophila models of neurodegenerative disease.

Authors:  Tzu-Kang Sang; George R Jackson
Journal:  NeuroRx       Date:  2005-07

4.  Caspases as therapeutic targets in Alzheimer's disease: is it time to "cut" to the chase?

Authors:  Troy T Rohn; Elizabeth Head
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

5.  Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline.

Authors:  Liliana B Menalled; Monica Patry; Natalie Ragland; Phillip A S Lowden; Jennifer Goodman; Jennie Minnich; Benjamin Zahasky; Larry Park; Janet Leeds; David Howland; Ethan Signer; Allan J Tobin; Daniela Brunner
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

6.  Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease.

Authors:  Rita Costa; Elena Speretta; Damian C Crowther; Isabel Cardoso
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

7.  Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.

Authors:  Carl M Sellgren; Jessica Gracias; Bradley Watmuff; Jonathan D Biag; Jessica M Thanos; Paul B Whittredge; Ting Fu; Kathleen Worringer; Hannah E Brown; Jennifer Wang; Ajamete Kaykas; Rakesh Karmacharya; Carleton P Goold; Steven D Sheridan; Roy H Perlis
Journal:  Nat Neurosci       Date:  2019-02-04       Impact factor: 24.884

Review 8.  Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.

Authors:  Pawel M Switonski; Wojciech J Szlachcic; Agnieszka Gabka; Wlodzimierz J Krzyzosiak; Maciej Figiel
Journal:  Mol Neurobiol       Date:  2012-09-04       Impact factor: 5.590

9.  Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study.

Authors:  Emily L Ho; Serena S Spudich; Evelyn Lee; Dietmar Fuchs; Elizabeth Sinclair; Richard W Price
Journal:  AIDS Res Ther       Date:  2011-05-12       Impact factor: 2.250

10.  The efficacy of tetracyclines in peripheral and intracerebral prion infection.

Authors:  Ada De Luigi; Laura Colombo; Luisa Diomede; Raffaella Capobianco; Michela Mangieri; Claudia Miccolo; Lucia Limido; Gianluigi Forloni; Fabrizio Tagliavini; Mario Salmona
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.